Knowledge, attitude and perceptions of pharmacists regarding renal dose adjustment among chronic kidney disease patients in Pakistan

References

• Imtiaz S, Salman B, Qureshi R, et al.A review of the epidemiology of chronic kidney disease in Pakistan: a global and regional perspectiveSaudi J Kidney Dis Transpl.201829614411451
   PubMed Web of Science ®Google Scholar
• Hasan M, Sutradhar I, Gupta RD, et al.Prevalence of chronic kidney disease in South Asia: a systematic reviewBMC Nephrol2018191291
   PubMed Web of Science ®Google Scholar
• Santos-Díaz G, Pérez-Pico AM, Suárez-Santisteban MÁ, et al.Prevalence of potential drug–drug interaction risk among chronic kidney disease patients in a Spanish hospitalPharmaceutics2020128713
   PubMed Web of Science ®Google Scholar
• Webster AC, Nagler EV, Morton RL, et al.Chronic kidney diseaseLancet20173891007512381252
   PubMed Web of Science ®Google Scholar
• Banerjee D, Winocour P, Chowdhury TA, et al.Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021BMC Nephrol20222319
   PubMed Web of Science ®Google Scholar
• Imtiaz S, Alam AEpidemiology and demography of chronic kidney disease in Pakistan-a review of Pakistani literaturePak J Kidney Dis20237127
   Google Scholar
• Alam A, Amanullah F, Baig-Ansari N, et al.Prevalence and risk factors of kidney disease in urban Karachi: baseline findings from a community cohort studyBMC Res Notes201471111
   PubMedGoogle Scholar
• Holm H, Bjerke K, Holst L, et al.Use of renal risk drugs in patients with renal impairmentInt J Clin Pharm201537611361142
   PubMed Web of Science ®Google Scholar
• Verbeeck RK, Musuamba FTPharmacokinetics and dosage adjustment in patients with renal dysfunctionEur J Clin Pharmacol2009658757773
   PubMed Web of Science ®Google Scholar
• Teh XR, Lee SWHPharmacists’ attitude, self-reported knowledge and practice of dosage adjustment among chronic kidney disease patients in MalaysiaJ Pharm Pract Res2019492179185
   Google Scholar
• Drenth-van Maanen AC, van Marum RJ, Jansen PA, et al.Adherence with dosing guideline in patients with impaired renal function at hospital dischargePLoS ONE2015106e0128237
   PubMed Web of Science ®Google Scholar
• Fink JC, Chertow GMMedication errors in chronic kidney disease: one piece in the patient safety puzzleKidney Int2009761111231125
   PubMed Web of Science ®Google Scholar
• Hayat M, Ahmad N, Khan SLA, et al.Pattern, frequency and factors associated with inappropriate high dosing in chronic kidney disease patients at a tertiary care hospital in PakistanBMC Nephrol2023241118
   PubMed Web of Science ®Google Scholar
• Inoue Y, Takikawa M, Morita Y, et al.A comparison of pharmacists' role functions across various nations: the importance of screeningRes Soc Admin Pharm.2016122347354
   PubMed Web of Science ®Google Scholar
• Gheewala PA, Peterson GM, Curtain CM, et al.Impact of the pharmacist medication review services on drug-related problems and potentially inappropriate prescribing of renally cleared medications in residents of aged care facilitiesDrugs Aging20143111825835
   PubMed Web of Science ®Google Scholar
• Hassan Y, Al-Ramahi RJ, Aziz NA, et al.Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney diseaseAnn Pharmacother2009431015981605
   PubMed Web of Science ®Google Scholar
• Kondo Y, Ishitsuka Y, Shigemori E, et al.Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based surveyBMC Health Serv Res20141418
   PubMed Web of Science ®Google Scholar
• Lalonde L, Quintana-Barcena P, Lord A, et al.Community pharmacist training-and-communication network and drug-related problems in patients with CKD: a multicenter, cluster-randomized, controlled trialAm J Kidney Dis2017703386396
   PubMed Web of Science ®Google Scholar
• Andrade C, Menon V, Ameen S, et al.Designing and conducting knowledge, attitude, and practice surveys in psychiatry: practical guidanceIndian J Psychol Med2020425478481
   PubMedGoogle Scholar
• Karim S, Adnan M. Pharmacy practice in India. Pharmacy practice in developing countries: Elsevier; 2016. p. 117–146.
   Google Scholar
• American College of Clinical PharmacyThe definition of clinical pharmacyPharmacotherapy2008286816817
   PubMed Web of Science ®Google Scholar
• Ibrahim MIMIbrahim MIM, Wertheimer AI, Babar ZUDChapter 18 - Assessment of medication dispensing and extended community pharmacy servicesSocial and administrative aspects of pharmacy in low- and middle-income countries2018CambridgeAcademic Press295309
   Google Scholar
• ACCP. Pharmacy Demand Report (PDR) Occupation Definitions. https://www.aacp.org/article/pharmacy-demand-report-pdr-occupation-definitions. Accessed 7 Sep 2023.
   Google Scholar
• Daniel W. Biostatistics: A Foundation for analysis in the health sciences, 7th edR Wiley. New York. 1999;141(2).
   Google Scholar
• DailyTimes. Pakistan becomes world No 1 in diabetes 2023. https://dailytimes.com.pk/1094011/pakistan-becomes-world-no-1-in-diabetes/. Accessed 3 June 2023.
   Google Scholar
• Azeem S, Khan U, Liaquat AThe increasing rate of diabetes in Pakistan: A silent killerAnn Med Surg.202279103901
   PubMed Web of Science ®Google Scholar
• Iqbal M, Akram M, Rashid A, et al.Prevalence of hypertension and associated co-morbidities in PakistanMathews J Nurs Health Care20235117
   Google Scholar
• Jessani S, Bux R, Jafar THPrevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan-a community based cross-sectional studyBMC Nephrol20141519
   PubMed Web of Science ®Google Scholar
• Duan J, Wang C, Liu D, et al.Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional surveySci Rep20199110408
   PubMedGoogle Scholar
• Ali ISyndemics at play: chronic kidney disease, diabetes and COVID-19 in PakistanAnn Med2021531581586
   PubMed Web of Science ®Google Scholar
• Boussadi A, Caruba T, Karras A, et al.Validity of a clinical decision rule-based alert system for drug dose adjustment in patients with renal failure intended to improve pharmacists’ analysis of medication orders in hospitalsInt J Med Inform20138210964972
   PubMed Web of Science ®Google Scholar
• Al-Abdelmuhsin L, Al-Ammari M, Babelghaith SD, et al., editors. Assessment of pharmacists’ knowledge and practices towards prescribed medications for dialysis patients at a tertiary hospital in Riyadh Saudi Arabia. Healthcare; 2021: MDPI.
   Google Scholar
• Wallace KL, Beckett RD, Sheehan AHPharmacist perception and use of UpToDate®J Med Library Assoc20141024296
   PubMed Web of Science ®Google Scholar
• Syed Sulaiman SA, Tariq MH. Evaluation of pharmacist's knowledge regarding chronic kidney disease. Arch Phar Pract. 2020;11(4).
   Google Scholar
• Ahmed JAzhar SUl Haq NetalAwareness of chronic kidney disease, medication, and laboratory investigation among nephrology and urology patients of Quetta, PakistanInt J Environ Res Public Health20221995015
   PubMed Web of Science ®Google Scholar
• Alahdal AM, Elberry AAEvaluation of applying drug dose adjustment by physicians in patients with renal impairmentSaudi Pharm J2012203217220
   PubMed Web of Science ®Google Scholar
• Saad R, Hallit S, Chahine BEvaluation of renal drug dosing adjustment in chronic kidney disease patients at two university hospitals in LebanonPharm Pract20191711304
   PubMed Web of Science ®Google Scholar
• Joosten H, Drion I, Boogerd KJ, et al.Optimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: improving drug safety in primary healthcare by low eGFR alertsBMJ Open201331e002068
   PubMed Web of Science ®Google Scholar